In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Meda Pharmaceuticals Inc.

Division of Mylan NV
www.medapharma.us

Latest From Meda Pharmaceuticals Inc.

Scrip 100 Analysis: Sales Up, Profits Down – But Is It Real?

Bellwethers tell you something, but to gauge the health of the pharmaceutical industry, you really need the Scrip 100. For FY 2016, it looks like drug sales are up again and profits are down. But is this what's actually going on?

Scrip 100 Sales & Earnings

ANDA Litigation Soars In 2014-2015; Patent Office Petitions Also Jump

Purdue's OxyContin and Amarin's Vascepa lead the list of targets as an increasing number of generic firms take up litigation.

BioPharmaceutical United States

Mylan To Catch M&A Train, But When?

CEO says generics firm is looking at potential transactions and hopes to complete one by the end of the year.

BioPharmaceutical United States

Lundbeck Onfi Gets Dermatological Warning, Bigger Marketing Challenge

Labeling for Eisai’s Banzel, which also has an indication limited to Lennox-Gastaut syndrome, does not mention Stevens-Johnson syndrome or toxic epidermal necrolysis cited in the Onfi warning.

BioPharmaceutical North America
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Immune Disorders
  • Neurology, Nervous System
  • Respiratory, Pulmonary
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Mylan NV
  • Senior Management
  • Sharon S Clarke, Pres.
    Jeffrey N Hostler, VP, Fin.
    Dennis Fuge, VP, Mktg.
    Richard N Spivey, SVP, R&D
  • Contact Info
  • Meda Pharmaceuticals Inc.
    Phone: (732) 564-2200
    265 Davidson Ave.
    Ste. 300
    Somerset, NJ 08873
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register